Peggy M. L. H. Vencken, Mieke Kriege, Maartje Hooning, Marian B. Menke-Pluymers, Bernadette A. M. Heemskerk-Gerritsen, Lena C. van Doorn, Margriet M. Collée, Agnes Jager, Cees van Montfort, Curt W. Burger and Caroline Seynaeve The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers Cancer 119
Version of Record online: 16 NOV 2012 | DOI: 10.1002/cncr.27839
In patients with breast cancer susceptibility gene (BRCA)-associated ovarian cancer, the risk of breast cancer is lower than in mutation carriers without ovarian cancer and is lower than the risk of dying from ovarian cancer. The current data may contribute to tailored counseling for these patients.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field